quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:33:28·798d
INSIDERFiling
Gemini Therapeutics Inc. logo

SEC Form 3 filed by new insider Franchi Jean M.

GMTX· Gemini Therapeutics Inc.
Health Care
Original source

Companies

  • GMTX
    Gemini Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 11UpdateHC Wainwright & Co.$2.00
  • Mar 3UpdateSVB Leerink$2.00
  • Mar 1UpdateJefferies$1.50
  • Jan 24UpdateSVB Leerink$10.00
  • Dec 20UpdateSVB Leerink$15.00
  • Dec 15UpdateHC Wainwright & Co.$20.00

Related

  • INSIDER798d
    Franchi Jean M. was granted 36,666 shares (SEC Form 4)
  • 13D/G799d
    SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
  • 13D/G800d
    SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
  • 13D/G804d
    SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
  • SEC806d
    Gemini Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure
  • 13D/G806d
    SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)
  • 13D/G819d
    SEC Form SC 13D/A filed by Gemini Therapeutics Inc. (Amendment)
  • INSIDER819d
    Bitterman Kevin sold $6,934,125 worth of shares (102,500 units at $67.65) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022